Higher Vitamin D Levels Tied to Lower Risk of Colorectal Cancer

Share this content:
Higher Vitamin D Levels Tied to Lower Risk of Colorectal Cancer
Higher Vitamin D Levels Tied to Lower Risk of Colorectal Cancer

FRIDAY, June 15, 2018 (HealthDay News) -- Higher circulating levels of vitamin D are tied to significantly lower colorectal cancer risk, particularly in women, according to a study published online June 14 in the Journal of the National Cancer Institute.

Marjorie L. McCullough, Sc.D., from the American Cancer Society in Atlanta, and colleagues pooled participant-level data from 17 cohorts consisting of 5,706 colorectal cancer case participants and 7,107 control participants in order to assess the association between circulating vitamin D levels and colorectal cancer risk.

The researchers found that deficient 25(OH)D levels (<30 nmol/L) were associated with 31 percent higher colorectal cancer risk (relative risk [RR], 1.31), while 25(OH)D levels above sufficiency (75 to ≤87.5 and 87.5 to <100 nmol/L) were associated with lower risk (RR, 0.81 and 0.73, respectively), compared to those within the lower range of sufficiency for bone health (50 to <62.5 nmol/L). The risk did not continue to decline with 25(OH)D ≥100 nmol/L. Colorectal cancer risk was 19 percent lower in women (RR, 0.81; 95 percent confidence interval, 0.75 to 0.87) and 7 percent lower in men (RR, 0.93; 95 percent confidence interval, 0.86 to 1) for each 25 nmol/L increment in circulating 25(OH)D.

"Optimal 25(OH)D concentrations for colorectal cancer risk reduction, 75 to 100 nmol/L, appear higher than current Institute of Medicine recommendations," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »